The news story you are looking for has expired. A more recent related article is displayed below.

Sponsored Links

GeneNews signs agreement with Eli Lilly and Company

Oct 28, 2009 (Datamonitor Financial Deals Tracker via COMTEX) --

Companies: Eli Lilly & Co. (LLY), GeneNews Ltd (GNWSF)

GeneNews Limited, a Canada-based molecular diagnostics company, has entered into an agreement with Eli Lilly and Company, under which Eli Lilly would have a selective access to research from its osteoarthritis genomic biomarker program. Eli Lilly is a US-based pharmaceutical company. 

Deal Type    Partnership
Sub-Category Licensing Agreement
Deal Status  Announced: 2009-10-27

Deal Participants 

Partner 1 (Company) Eli Lilly and Company
Partner 2 (Company) GeneNews Limited

Copyright (C) 2009 Datamonitor Financial Deals Tracker. All rights reserved

News Provided by COMTEX

Companies: Eli Lilly & Co. (LLY), GeneNews Ltd (GNWSF)


Related terms: canada, partnership, pharmaceuticals, research

Related Articles

GeneNews Provides Eli Lilly and Company with Access to its Osteoarthritis Biomarker Program - News,
Oct 27, 2009
...CAREER FAIRS COMPANY PROFILES RESEARCH... PROFILES Company Profiles START UPS Companies Events INTELLIGENCE...TO) Provides Eli Lilly and Company (LLY) (JOBS...its Osteoarthritis Biomarker Program 10/27/2009...

Robbins Graphics Upgrades to a ValueJet 1614 Printer
Oct 21, 2009
...ValueJet 1614-64" printing system. Company Supplied -- Graphic Arts Online...brokers, advertising and marketing companies, builders and developers, museums, Eli Lilly, and The Indianapolis Zoo. Company Supplied

GeneNews provides Lilly with access to its osteoarthritis biomarker program - Zibb.com
Oct 27, 2009
...osteoarthritis biomarker program GeneNews...GEN), a company focused on...agreement allowing Eli Lilly and Company (NYSE: LLY...osteoarthritis genomic biomarker program. Terms of...partners." Eli Lilly and Company is developing...

Big banks, big pharma, big problems
Oct 12, 2009
...large pharmaceutical companies carries a social responsibility...between society and drug companies has not been fulfilled...about $6 billion, Eli Lilly $3bn, and GlaxoSmithKline...20 pharmaceutical company has access to about...mountain of the top 20 companies is probably unthinkable...